Research News for May 11, 2022
advertisement
- FDA places hold on trial of novel cell therapy for type 1 diabetes
- Recombinant human glutamic acid decarboxylase may preserve C-peptide in type 1 diabetes
- Identification of miRNA-mRNA-TF regulatory networks in peripheral blood mononuclear cells of type 1 diabetes
- Recent Advances in Immune-based Therapies for Type 1 Diabetes
- Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes (Full text HTML, PDF)
- rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes (Full text HTML, PDF)
- Host gene effects on gut microbiota in type 1 diabetes
- Temporal regulation of interferon signalling in human EndoC-βH1 cells
- Engineering Vascularized Islet Macroencapsulation Devices: An in vitro Platform to Study Oxygen Transport in Perfused Immobilized Pancreatic Beta Cell Cultures (Full text HTML, PDF)
- Comparison of alpha 1- antitrypsin activity and phenotype in type 1 diabetic patients to healthy individuals (Full text HTML, PDF)
- CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus (Full text HTML)
